Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AML and High Risk MDS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00778375
What this trial is testing

Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 122
Early research (Phase 1)Looking for participantsNCT07107126
What this trial is testing

Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Remedy Plan, Inc. 24
Not applicableLooking for participantsNCT01311258
What this trial is testing

Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
University of Rochester 400
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Early research (Phase 1)UnknownNCT01277484
What this trial is testing

Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Seoul St. Mary's Hospital 19
Not applicableEnded earlyNCT04185428
What this trial is testing

Investigating Integrative Therapies for Symptom Management in Adults With Acute Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Florida 9
Testing effectiveness (Phase 2)UnknownNCT03454984
What this trial is testing

SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Groupe Francophone des Myelodysplasies 40
Early research (Phase 1)Study completedNCT05775406
What this trial is testing

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

Who this might be right for
Myeloid MalignanciesAcute Lymphocytic LeukemiaLymphomas+1 more
Kymera Therapeutics, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT00045942
What this trial is testing

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Novartis Pharmaceuticals 144
Early research (Phase 1)Study completedNCT02996773
What this trial is testing

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+10 more
University of Arizona 50
Testing effectiveness (Phase 2)Study completedNCT00882102
What this trial is testing

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 43
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Post-approval studies (Phase 4)Study completedNCT03176849
What this trial is testing

Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT

Who this might be right for
Vitamin D DeficiencyStem Cell Transplant ComplicationsPediatric Cancer+7 more
Phoenix Children's Hospital 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT01522976
What this trial is testing

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+4 more
National Cancer Institute (NCI) 282
Testing effectiveness (Phase 2)Looking for participantsNCT03999723
What this trial is testing

Combining Active and Passive DNA Hypomethylation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Kirsten Grønbæk 196
Testing effectiveness (Phase 2)Ended earlyNCT01135329
What this trial is testing

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Who this might be right for
LymphomaLeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Early research (Phase 1)WithdrawnNCT02487459
What this trial is testing

Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Bellicum Pharmaceuticals
Early research (Phase 1)Active Not RecruitingNCT05455294
What this trial is testing

Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms

Who this might be right for
Myeloid MalignancyMyelodysplastic SyndromesMyelofibrosis+2 more
Jacqueline Garcia, MD 16
Testing effectiveness (Phase 2)UnknownNCT04964518
What this trial is testing

APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
AML, Adult
Ascentage Pharma Group Inc. 24
Next Page